Artificial intelligence (AI) cerebrovascular software developer RapidAI has named Amit Phadnis as the company's new chief innovation and technology officer.
Phadnis will oversee RapidAI's efforts in R&D and engineering and technology to advance the company's AI platform for neurovascular and vascular disease care.
Prior to joining RapidAI, Phadnis was chief digital officer at GE Healthcare. In his role at GE, he was responsible for driving the company's digital and AI strategy, as well as GE Healthcare's complete digital portfolio, including enterprise imaging solutions, clinical command centers, and consulting solutions.
Phadnis holds a master's degree in electronics and communication from the Indian Institute of Science.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
